Mats Kvarnström

451 total citations · 1 hit paper
6 papers, 332 citations indexed

About

Mats Kvarnström is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mats Kvarnström has authored 6 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mats Kvarnström's work include Lipid metabolism and disorders (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Mats Kvarnström is often cited by papers focused on Lipid metabolism and disorders (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Mats Kvarnström collaborates with scholars based in Sweden, United States and Netherlands. Mats Kvarnström's co-authors include Jan Oscarsson, Gun‐Britt Forsberg, L. E. B. Johansson, Ulf Risérus, Per‐Anders Jansson, Lars Lind, Jan W. Eriksson, Per Lundkvist, Tasso Miliotis and Catarina Nilsson and has published in prestigious journals such as Gastroenterology, Diabetologia and Atherosclerosis.

In The Last Decade

Mats Kvarnström

5 papers receiving 326 citations

Hit Papers

Effects of dapagliflozin and n-3 carboxylic acids on non-... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers

Mats Kvarnström
Philip Home United Kingdom
Arun J. Sanyal United States
Samina Ajaz Hussain United States
Wael Youssef United States
R Conti Italy
Cameron Gofton Australia
Mats Kvarnström
Citations per year, relative to Mats Kvarnström Mats Kvarnström (= 1×) peers Barbara Fruci

Countries citing papers authored by Mats Kvarnström

Since Specialization
Citations

This map shows the geographic impact of Mats Kvarnström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Kvarnström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Kvarnström more than expected).

Fields of papers citing papers by Mats Kvarnström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Kvarnström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Kvarnström. The network helps show where Mats Kvarnström may publish in the future.

Co-authorship network of co-authors of Mats Kvarnström

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Kvarnström. A scholar is included among the top collaborators of Mats Kvarnström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Kvarnström. Mats Kvarnström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Dunbar, Richard L., Daniel Gaudet, Michael H. Davidson, et al.. (2020). Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids in Health and Disease. 19(1). 117–117. 5 indexed citations
2.
Lindkvist, Björn, Catarina Nilsson, Mats Kvarnström, & Jan Oscarsson. (2018). Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: A randomized crossover study. Pancreatology. 18(5). 550–558. 17 indexed citations
3.
Eriksson, Jan W., Per Lundkvist, Per‐Anders Jansson, et al.. (2018). Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia. 61(9). 1923–1934. 287 indexed citations breakdown →
4.
Stroes, Erik S.G., Andrey V. Susekov, Tjerk W.A. de Bruin, et al.. (2017). Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. Journal of clinical lipidology. 12(2). 321–330. 19 indexed citations
6.
Stroes, Erik S.G., et al.. (2016). Omega-3 carboxylic acids in severe hypertriglyceridemia: EVOLVE II study results. Atherosclerosis. 252. e232–e232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026